H.C. Wainwright Reiterates Buy Rating on Protera Therapeutics (TARA), 'TARA-002 holds an attractive position in the treatment of NMIBC'
Go back to H.C. Wainwright Reiterates Buy Rating on Protera Therapeutics (TARA), 'TARA-002 holds an attractive position in the treatment of NMIBC'| (NASDAQ: TARA) | Delayed: 3.97 +0.03 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.94 | 52 Week High | $ | |||
| Open | $3.94 | 52 Week Low | $ | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $3.83 | EPS | $ | |||
| Volume | 333,245 | |||||
